A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy
Clinical trial NCT01940887 · TERMINATED
Trial details
- NCT number
- NCT01940887
- Sponsor
- Ophthotech Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-06-01
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.